Axon Enterprise, Inc. (AAXN) EPS Estimated At $0.04

July 14, 2018 - By Jeanette Kaplan

Analysts expect Axon Enterprise, Inc. (NASDAQ:AAXN) to report $0.04 EPS on August, 14.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.04 EPS. AAXN’s profit would be $2.33 million giving it 423.69 P/E if the $0.04 EPS is correct. After having $0.24 EPS previously, Axon Enterprise, Inc.’s analysts see -83.33 % EPS growth. The stock decreased 1.67% or $1.15 during the last trading session, reaching $67.79. About 627,763 shares traded. Axon Enterprise, Inc. (NASDAQ:AAXN) has risen 152.14% since July 14, 2017 and is uptrending. It has outperformed by 139.57% the S&P500.

Axon Enterprise, Inc. develops, manufactures, and sells conducted electrical weapons worldwide. The company has market cap of $3.95 billion. The firm operates through two divisions, TASER Weapons and Axon. It has a 269.01 P/E ratio. It offers TASER X26P and TASER X2 smart weapons for law enforcement; TASER C2 and TASER Pulse CEWs for the consumer market; and replacement cartridges.

More notable recent Axon Enterprise, Inc. (NASDAQ:AAXN) news were published by: which released: “Don’t Sell Axon Enterprise – Cramer’s Lightning Round (7/11/18)” on July 12, 2018, also with their article: “4 Top-Ranked Nasdaq Stocks That Have Doubled This Year” published on June 14, 2018, published: “This Stock Is Up 155% in 2018. Is It Still a Buy?” on June 28, 2018. More interesting news about Axon Enterprise, Inc. (NASDAQ:AAXN) were released by: and their article: “Axon Enterprise started at Overweight by Morgan Stanley” published on July 02, 2018 as well as‘s news article titled: “Why Axon Enterprise Inc.’s Stock Is Up 154% in 2018” with publication date: July 10, 2018.

Axon Enterprise, Inc. (NASDAQ:AAXN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: